Zhefeng Li

2.1k total citations · 1 hit paper
44 papers, 1.8k citations indexed

About

Zhefeng Li is a scholar working on Molecular Biology, Cancer Research and Materials Chemistry. According to data from OpenAlex, Zhefeng Li has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Cancer Research and 12 papers in Materials Chemistry. Recurrent topics in Zhefeng Li's work include Lanthanide and Transition Metal Complexes (12 papers), RNA Interference and Gene Delivery (8 papers) and MicroRNA in disease regulation (6 papers). Zhefeng Li is often cited by papers focused on Lanthanide and Transition Metal Complexes (12 papers), RNA Interference and Gene Delivery (8 papers) and MicroRNA in disease regulation (6 papers). Zhefeng Li collaborates with scholars based in China, United States and Australia. Zhefeng Li's co-authors include Peixuan Guo, Hongjie Zhang, Liang Zhou, Ruiping Deng, Jiangbo Yu, Hongzhi Wang, Bin Guo, Hongran Yin, Zeping Peng and Chad Bennett and has published in prestigious journals such as ACS Nano, PLoS ONE and Nature Nanotechnology.

In The Last Decade

Zhefeng Li

42 papers receiving 1.8k citations

Hit Papers

Nanoparticle orientation to control RNA loading and ligan... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression
    2017 417 citations Zhefeng Li, Bin Guo et al. profile →

Peers

Zhefeng Li
Yan Guo China
Matthew S. Tremblay United States
Yuanhua Ding China
Xiangdan Meng China
Raghavendra Kikkeri India
Shixin Zhou China
Qi Xiao United States
Motoi Oishi Japan
Yan Guo China
Zhefeng Li
Citations per year, relative to Zhefeng Li Zhefeng Li (= 1×) peers Yan Guo

Countries citing papers authored by Zhefeng Li

Since Specialization
Citations

This map shows the geographic impact of Zhefeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhefeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhefeng Li more than expected).

Fields of papers citing papers by Zhefeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhefeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhefeng Li. The network helps show where Zhefeng Li may publish in the future.

Co-authorship network of co-authors of Zhefeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhefeng Li. A scholar is included among the top collaborators of Zhefeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhefeng Li. Zhefeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Lisha, Mei Jiang, Yue Li, et al.. (2025). Targeting SPP1+ macrophages via the SPP1-CD44 axis reveals a key mechanism of immune suppression and tumor progression in ovarian cancer. International Immunopharmacology. 160. 114906–114906. 4 indexed citations
2.
Li, Zhefeng, Jie Li, Yue Li, et al.. (2025). Single-cell transcriptomics identify a chemotherapy-resistance related cluster overexpressed CLIC3 in ovarian cancer. Discover Oncology. 16(1). 1099–1099.
3.
4.
5.
Li, Jie, Zhefeng Li, Junjie Yi, et al.. (2023). Single-cell transcriptomics in ovarian cancer identify a metastasis-associated cell cluster overexpressed RAB13. Journal of Translational Medicine. 21(1). 254–254. 16 indexed citations
6.
Gao, Yan, Hui Shi, Hongyu Zhao, et al.. (2023). Single‐cell transcriptomics identify TNFRSF1B as a novel T‐cell exhaustion marker for ovarian cancer. Clinical and Translational Medicine. 13(9). e1416–e1416. 14 indexed citations
7.
Cui, Xuemei, Xuefeng Li, Qiang Wei, et al.. (2022). Effects of Dietary Coated Lysozyme on the Growth Performance, Antioxidant Activity, Immunity and Gut Health of Weaned Piglets. Antibiotics. 11(11). 1470–1470. 9 indexed citations
8.
Li, Jie, Zhefeng Li, Yan Gao, et al.. (2022). Integrating single-cell RNA sequencing and prognostic model revealed the carcinogenicity and clinical significance of FAM83D in ovarian cancer. Frontiers in Oncology. 12. 1055648–1055648. 9 indexed citations
9.
Li, Zhefeng, et al.. (2021). Non-Small-Cell Lung Cancer Regression by siRNA Delivered Through Exosomes That Display EGFR RNA Aptamer. Nucleic Acid Therapeutics. 31(5). 364–374. 43 indexed citations
10.
Zhao, Hongyu, Yan Gao, Suwen Chen, et al.. (2021). Single-cell RNA-seq highlights a specific carcinoembryonic cluster in ovarian cancer. Cell Death and Disease. 12(11). 1082–1082. 16 indexed citations
11.
Zhao, Xiaoting, Mei Jiang, Teng Yu, et al.. (2021). Cytoplasmic Localization Isoform of Cyclin Y Enhanced the Metastatic Ability of Lung Cancer via Regulating Tropomyosin 4. Frontiers in Cell and Developmental Biology. 9. 684819–684819. 6 indexed citations
12.
Zhang, Yue, et al.. (2021). International trends in ovarian cancer incidence from 1973 to 2012. Archives of Gynecology and Obstetrics. 303(6). 1589–1597. 11 indexed citations
13.
Zhao, Hongyu, Zhefeng Li, Jie Li, et al.. (2021). Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis. Journal of Ovarian Research. 14(1). 46–46. 5 indexed citations
14.
Xu, Congcong, Kaiming Zhang, Hongran Yin, et al.. (2020). 3D RNA nanocage for encapsulation and shielding of hydrophobic biomolecules to improve the in vivo biodistribution. Nano Research. 13(12). 3241–3247. 6 indexed citations
15.
Zheng, Zhen, Zhefeng Li, Congcong Xu, Bin Guo, & Peixuan Guo. (2019). Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping. Journal of Controlled Release. 311-312. 43–49. 121 indexed citations
16.
Li, Zhefeng, Hongzhi Wang, Hongran Yin, et al.. (2018). Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression. Scientific Reports. 8(1). 14644–14644. 209 indexed citations
17.
Jasinski, Daniel L., Hongran Yin, Zhefeng Li, & Peixuan Guo. (2017). Hydrophobic Effect from Conjugated Chemicals or Drugs on In Vivo Biodistribution of RNA Nanoparticles. Human Gene Therapy. 29(1). 77–86. 25 indexed citations
18.
Yan, Hede, Bin Zhao, Zhefeng Li, et al.. (2013). The Effect of Hemodynamic Remodeling on the Survival of Arterialized Venous Flaps. PLoS ONE. 8(11). e79608–e79608. 11 indexed citations
19.
Feng, Jing, Liang Zhou, Shuyan Song, et al.. (2009). A study on the near-infrared luminescent properties of xerogel materials doped with dysprosium complexes. Dalton Transactions. 6593–6593. 57 indexed citations
20.
Jiao, Wei, et al.. (2009). Lathyrane diterpenes from Euphorbia lathyris as modulators of multidrug resistance and their crystal structures. Bioorganic & Medicinal Chemistry. 17(13). 4786–4792. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Guo Breakdown of academic impact, for papers by Matthew S. Tremblay Breakdown of academic impact, for papers by Yuanhua Ding Breakdown of academic impact, for papers by Xiangdan Meng Breakdown of academic impact, for papers by Raghavendra Kikkeri Breakdown of academic impact, for papers by Shixin Zhou Breakdown of academic impact, for papers by Qi Xiao Breakdown of academic impact, for papers by Motoi Oishi
Rankless by CCL
2026